what is glp and glp 1 Can one drug do it all? Reviewing the expanding clinical universe of GLP-1 agonists PDB-101: Molecule of the Month:

Interested in science from a young age, most of Bloom's career has been focused on gut hormones

Whether you're looking to lose those few stubborn pounds and tone your body or tackle a bigger weight loss goal, there are many reasons you may feel stuck on your weight loss journey

Comprehensive review of currently available glucose-lowering therapies for the treatment of T2DM, focusing on mechanisms of action, pharmacokinetics, pharmacodynamics and safety profiles

Mounjaro (tirzepatide) GLP-1 + GIP In SURMOUNT-1 (72 weeks), average weight loss at the highest dose was often quoted around: ~22.5% (highest dose) What that looks like: If you start at 100 kg , ~22.5% is about 2223 kg lost on average

Multi-faced neuroprotective effects of geniposide depending on the RAGE-mediated signaling in an Alzheimer mouse model

In this context, the data currently available on tirzepatide, showing its efficacy in glycemic control to the extent that a considerable percentage of patients achieve glucose levels indicative of diabetes remission [3, 59], as well as its high effectiveness in weight management, are promising regarding its future use in clinical practice